Home > Tacere Therapeutics Salary

Tacere Therapeutics Salary

  • 74
  • 89
  • 30
Tacere Therapeutics average salary is $59,300, median salary is $59,300 with a salary range from $51,000 to $67,600.
Tacere Therapeutics salaries are collected from government agencies and companies. Each salary is associated with a real job position. Tacere Therapeutics salary statistics is not exclusive and is for reference only. They are presented "as is" and updated regularly.
Low
51,000
Average
59,300
Median
59,300
High
67,600
Total 2 Tacere Therapeutics Salaries. Sorted by Date, page 1
Ranked By:
Job Title Salaries City Year More info
Production Coordinator 67,600-67,600 New York, NY, 10001 2017 Tacere Therapeutics Production Coordinator Salaries (1)
Tacere Therapeutics New York, NY Salaries
Compliance Manager 51,000-51,000 New York, NY, 10001 2015 Tacere Therapeutics Compliance Manager Salaries (1)
Tacere Therapeutics New York, NY Salaries
Calculate how much you could earn

It's FREE. Based on your input and our analysis.     How we do it?

All fields are required for calculation accuracy.

  • We will send you an email to access your personalized report.
  • We won’t share your email address

Tacere Therapeutics salary is full-time annual starting salary. Intern, contractor and hourly pay scale vary from regular exempt employee. Compensation depends on work experience, job location, bonus, benefits and other factors.

Real Jobs Salary - Salary List
Calculate Your Salary Ranking
Tacere Therapeutics Jobs
See more Tacere Therapeutics Jobs»
Search All Jobs

JobCompare – Find open jobs faster
Tacere Therapeutics... Information
  • Tacere Therapeutics, Inc
  • Industry: Biotech/Healthcare
  • City: San Jose, CA
  • Tacere is an innovative biotechnology company focused on developing therapeutics to treat serious infectious diseases using its proprietary knowledge in the screening and development of both novel and traditional compounds. Tacere is located in San Jose, California, USA. Its lead therapeutic compound is TT-033i, an RNA interference (RNAi) drug for the treatment of Hepatitis C.